Abstract
Негормональные лекарственные средства имеют сходную эффективность в купировании АМ без анатомического субстрата, но уступают КОК. При хронических АМК средствами первой линии являются ВМС-ЛНГ и КОК, содержащие Э2В/ДНГ, которые способствуют нормализации менструального цикла и объема менструальной кровопотери с доказанной эффективностью.
References
Fraser I.S., Critchley H.O., Broder M., Munro M.G. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med. 2011; 29(5): 383-90.
Management of acute abnormal uterine bleeding in nonpregnant reproductive aged women. American College of Obstetricians and Gynecologists. Committee Opinion No. 557. Obstet Gynecol. 2013; 121(4): 891-896.
Matteson K.A., Abed H., Wheeler T.L., Sung V.W. et al. A systematic review comparing hysterectomy with less-invasive treatments for abnormal uterine bleeding. J Minim Invasive Gynecol. 2012; 19(1): 13–28.
Munro M.G., Critchley H.O., Broder M.S., Fraser I.S. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. FIGO Working Group on Menstrual Disorders. Int J Gynaecol Obstet. 2011; 113(3): 3-13.
National Collaborating Centre for Women’s and Children’s Health, National Institute of Clinical Excellence. Heavy menstrual bleeding. Clinical guideline 44. London: RCOG Press; 2007. UpDate 2018. Available at: http://www.nice.org.uk.
Ferin M. The Hypothalamic-HypophysealOvarian Axis and the Menstrual Cycle. Glob. libr. women’s med. 2008 (ISSN: 1756-2228) [web] [viewed 31 August 2014] Available from: http://www.glowm.com.
Kadir R.A., Economides D.L., Sabin C.A., Owens D., Lee C.A. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet. 1998; 351(9101): 485-9.
Munro M.G. Abnormal Uterine Bleeding. Cambridge University Press. 2010:978-0-521-72183-7.
Kolev К, Longstaff С. Bleeding related to disturbed fibrinolysis. Br J Haematol. 2016; 175(1): 12–23.
Toth M., Patton D.L., Esquenazi B., Shevchuk M., Thaler H., Divon M. Association between Chlamydia trachomatis and abnormal uterine bleeding. Am J Reprod Immunol. 2007; 57(5): 361-6.
Bradley L.D., Gueye N.A. The medical management of abnormal uterine bleeding in reproductive-aged women. Am J Obstet Gynecol. 2016; 214(1): 31-44.
Lethaby A., Farquhar C., Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database of Systematic Reviews. 2000, Issue 4. Art. No.: CD000249.
DeVore G.R., Owens O., Kase N. Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding—a double-blind randomized control study. Obstet Gynecol. 1982; 59: 285-91.
This work is licensed under a Creative Commons Attribution 4.0 International License.